PHASE I STUDY OF 5-FLUORODEOXYURIDINE PLUS CYTOSINE ARABINOSIDE INFUSIONS IN PATIENTS WITH SOLID TUMORSCUMMINGS FJ; HOOVIS ML; CALABRESI P et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 8; PP. 1371-1374; BIBL. 10 REF.Article

CLINICAL TRIAL OF WEEKLY PYRAZOFURINCUMMINGS FJ; STOLLER RG; KAPLAN HG et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 8; PP. 1363-1365; BIBL. 19 REF.Article

A CLINICAL AND PHARMACOLOGICAL STUDY OF HIGH-DOSE METHOTREXATE WITH MINIMAL LEUCOVORIN RESCUESTOLLER RG; KAPLAN HG; CUMMINGS FJ et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 3; PP. 908-912; BIBL. 14 REF.Article

EVALUATION OF CELL-MEDIATED REACTIVITY AND SERUM BLOCKING FACTORS IN MELANOMA PATIENTS ON CHEMOTHERAPYCUMMINGS FJ; HEPPNER GH; CALABRESI P et al.1975; MED. PEDIATR. ONCOL.; U.S.A.; DA. 1975; VOL. 1; NO 3; PP. 195-206; BIBL. 15 REF.Article

ADRIAMYCIN PLUS VINCRISTINE ALONE OR WITH DIBROMODULCITOL OR ICRF-159 IN METASTATIC BREAST CANCERCUMMINGS FJ; GELMAN R; TORMEY DC et al.1981; CANCER CLIN. TRIALS; ISSN 0190-1206; USA; DA. 1981; VOL. 4; NO 3; PP. 253-260; BIBL. 11 REF.Article

CELL-MEDIATED AND SERUM BLOCKING REACTIVITY TO TUMOR ANTIGENS IN PATIENTS WITH MALIGNANT MELANOMA = REACTIVITE A MEDIATION CELLULAIRE ET BLOCAGE SERIQUE A L'EGARD DES ANTIGENES TUMORAUX CHEZ LES MALADES ATTEINTS DE MELANOME MALINHEPPNER GH; STOLBACH L; BYRNE M et al.1973; INTERNATION. J. CANCER; SWITZ.; DA. 1973; VOL. 11; NO 2; PP. 245-260; ABS. FR.; BIBL. 23REF.Serial Issue

PHASE II TRIALS OF BAKER'S ANTIFOL, BLEOMYCIN, CCNU, STREPTOZOTOCIN, TILORONE, AND 5-FLUORODEOXYURIDINE PLUS ARABINOSYL CYTOSINE IN METASTATIC BREAST CANCERCUMMINGS FJ; GELMAN R; SKEEL RJ et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 48; NO 3; PP. 681-685; BIBL. 8 REF.Article

ULTRASTRUCTURE OF MYELOMA CELLS IN A CASE WITH CRYSTALCRYOGLOBULINEMIA.KALDERON AE; BOGAARS HA; DIAMOND I et al.1977; CANCER; U.S.A.; DA. 1977; VOL. 39; NO 4; PP. 1475-1481; BIBL. 20 REF.Article

CLINICAL AND PHARMACOLOGICAL STUDIES OF METHOTREXATE-MINIMAL LEUCOVORIN RESCUE PLUS FLUOROURACILWIEMANN MC; CUMMINGS FJ; KAPLAN HG et al.1982; CANCER RES.; USA; DA. 1982; VOL. 42; NO 9; PP. 3896-3900; BIBL. 29 REF.Article

SUCCESSFUL THERAPY OF CRYSTAL CRYOGLOBULINEMIA: A CASE REPORTCUMMINGS FJ; PARK CH; BOGAARS HA et al.1979; MED. PEDIATR. ONCOL.; USA; DA. 1979; VOL. 7; NO 2; PP. 181-190; BIBL. 14 REF.Article

HEMODYNAMIC EFFECTS OF POTENTIALLY USEFUL ANTINEOPLASTIC AGENTS = EFFETS HEMODYNAMIQUES D'AGENTS ANTINEOPLASIQUES POTENTIELSSPREMULLI EN; CUMMINGS FJ; CRABTREE GW et al.1983; JOURNAL OF THE NATIONAL CANCER INSTITUTE; ISSN 0027-8874; USA; DA. 1983; VOL. 70; NO 3; PP. 499-504; ABS. ENG; BIBL. 40 REF.; GRAPHArticle

MECHLORETHAMINE (NSC-762) PLUS CCNU (NSC-79037) IN THE TREATMENT OF INOPERABLE SQUAMOUS AND LARGE CELL CARCINOMA OF THE LUNGEDMONSON JH; LAGAKOS S; STOLBACH L et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 5; PP. 625-627; BIBL. 4 REF.Article